Debbie has a BSc(Hons) in pharmacology from Sheffield University and PhD from Imperial College London. She is a Fellow of the British Pharmacological Society (FBPhS) and a Fellow of the Royal Society Te Apārangi (FRSNZ). Research in the Hay laboratory focuses on the molecular pharmacology of receptors which are therapeutic targets for migraine, diabetes/obesity and cardiovascular disease. Debbie is a member of the IUPHAR Transparency and Reproducibility committee and advocates for accurate reporting of pharmacological research and the need for improving transparency, rigor and reproducibility.

In 2020, Michael obtained his PhD in Biological Sciences from the University of Auckland. He then moved to the University of Otago to help Prof. Debbie Hay to establish a research lab. In 2022 Michael was awarded with a Neurological Foundation of New Zealand First Fellowship to investigate CGRP and its related peptides and receptors in brain regions relevant to migraine. Michael is currently co-Principal Investigator on Marsden Funded project, alongside his mentor Prof Debbie Hay, continuing his work with CGRP in the context of migraine.

Amrita is a Principal Investigator at Queen Mary University of London leading the Vascular Pharmacology Group. She is a translational pharmacologist taking her basic bench discoveries to the clinical setting leading experimental medicine studies and several phase IIa and IIb studies. Her research focuses on understanding the role of inflammation in cardiac and vascular disease with a focus upon the non-canonical pathway for NO generation i.e. the nitrate-nitrite-NO pathway and delineating the mechanisms that underlie sex differences in cardiovascular physiology and disease. She received the GSK Prize for Clinical Pharmacology (2012) from the British Pharmacological Society and the Women In Science & Engineering (WISE) Prize for Research UK in 2015 and was awarded Fellowship of the Academy of Medical Sciences in 2024. She was recognised for her high impact work being one of the Clarivates most highly cited researchers in 2023 and 2024. Amrita was Editor-In-Chief of The British Journal of Pharmacology (2016-2022), a Fellow of The British Pharmacological Society and is Chair of the International Union of Basic and Clinical Pharmacology (IUPHAR) Basic & Translational Section (2022-2024) and a member of the NC3Rs Review Committee (2017-2021) and the ARRIVE Guidelines Panel. Amrita in her role as EiC of BJP has led several initiatives seeking to audit and then improve Reproducibility & Transparency within the pharmacology community. Amrita is also committed to equality in the workplace and has led numerous initiatives supporting both gender and racial equality in the workplace.

Farhad is a cell and molecular biologist and an early-career researcher in the School of Biomedical Sciences at The University of Queensland. He completed his PhD at UQ, followed by a postdoctoral fellowship at the Walter and Eliza Hall Institute, where he worked on an industry project developing inhibitors of cytokine signalling. In 2022, he joined A/Prof Furness’ Receptor Transducer Coupling Lab, focusing on G protein-coupled receptors. His research centres on single-molecule receptor dynamics and how signalling precision is achieved through shared transducer pathways. Farhad is committed to scientific integrity, and data transparency and reproducibility are core values that guide his research.